{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05821959",
            "orgStudyIdInfo": {
                "id": "AK-OTOF-101"
            },
            "organization": {
                "fullName": "Akouos, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss",
            "officialTitle": "A Trial of AAVAnc80-hOTOF Gene Therapy in Individuals With Sensorineural Hearing Loss Due to Otoferlin Gene Mutations",
            "therapeuticArea": [
                "Other"
            ],
            "study": "gene-therapy-trial-for-otoferlin-gene-mediated-hearing-loss"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-08",
            "studyFirstSubmitQcDate": "2023-04-18",
            "studyFirstPostDateStruct": {
                "date": "2023-04-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Akouos, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Eli Lilly and Company",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "Part A of this trial will evaluate the safety and tolerability of a single unilateral administration of one of two dose levels of AAVAnc80-hOTOF and will evaluate the Akouos delivery device to safely achieve the intended product performance.",
            "detailedDescription": "The following two dose levels will be tested sequentially:\n\n* 4.1E11 total vg/cochlea\n* 8.1E11 total vg/cochlea"
        },
        "conditionsModule": {
            "conditions": [
                "Sensorineural Hearing Loss, Bilateral"
            ],
            "keywords": [
                "Otoferlin",
                "Auditory neuropathy (AN)",
                "Deafness, autosomal recessive 9 (DFNB9)",
                "Hearing loss",
                "Hearing loss, bilateral",
                "Hearing loss, sensorineural"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 14,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1a and Cohort 1b",
                    "type": "EXPERIMENTAL",
                    "description": "Cohort 1a: Two participants aged 7 to 17 years old (inclusive) to receive intracochlear administration of AAVAnc80-hOTOF (dose level 1) in the study ear using a sterile, one-time use investigational medical device\n\nCohort 1b: Up to six eligible participants will be enrolled to receive intracochlear administration of AAVAnc80-hOTOF (dose level 1) in the study ear using a sterile, one-time use investigational medical device; the first three participants will be at least two years of age at the time of AAVAnc80-hOTOF administration and the next three participants may be of any age",
                    "interventionNames": [
                        "Combination Product: AAVAnc80-hOTOF via Akouos Delivery Device"
                    ]
                },
                {
                    "label": "Cohort 2",
                    "type": "EXPERIMENTAL",
                    "description": "Cohort 2: Up to six eligible participants will be enrolled to receive intracochlear administration of AAVAnc80-hOTOF (dose level 2) in the study ear using a sterile, one-time use investigational medical device; the first three participants will be at least two years of age at the time of AAVAnc80-hOTOF administration and the next three participants may be of any age",
                    "interventionNames": [
                        "Combination Product: AAVAnc80-hOTOF via Akouos Delivery Device"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "AAVAnc80-hOTOF via Akouos Delivery Device",
                    "description": "AAVAnc80-hOTOF is a sterile suspension intended to be administered via a one-time unilateral intracochlear administration using the Akouos Delivery Device.",
                    "armGroupLabels": [
                        "Cohort 1a and Cohort 1b",
                        "Cohort 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Frequency of Adverse Events (AEs)",
                    "description": "AEs with relationship to the investigational medicinal product and/or to the administration procedure (including the delivery device)",
                    "timeFrame": "through trial completion, approximately 1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Auditory Brainstem Response (ABR) Threshold",
                    "description": "Changes from baseline in ABR intensity threshold (decibels normal hearing level \\[dB nHL\\])",
                    "timeFrame": "through trial completion, approximately 1 year"
                },
                {
                    "measure": "Performance of the Akouos Delivery Device",
                    "description": "Performance based on the frequency of device deficiencies observed during delivery of AAVAnc80-hOTOF to the intracochlear space",
                    "timeFrame": "through trial completion, approximately 1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Criteria for Inclusion:\n\n1. Participants may be of any age, based on Cohort Criteria\n2. At least two mutations in the otoferlin gene\n3. Clinical presentation of Profound bilateral sensorineural hearing loss as assessed by ABR\n4. Preserved distortion product otoacoustic emissions (DPOAEs)\n5. Able and willing to comply with all study requirements, including willingness to participate in a separate long term follow-up study after completion of this trial\n\nCriteria for Exclusion:\n\n1. Persistent ear infections, anatomic or other abnormalities of the ear, and/or medical conditions that would contraindicate undergoing surgery, anesthesia, and/or administration of investigational gene therapy\n2. Bilateral cochlear implants\n3. Prior participation in a clinical trial with an investigational drug, within six months prior to administration, or any prior participation in a gene therapy clinical trial",
            "healthyVolunteers": false,
            "sex": "ALL",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Akouos Clinical Trials",
                    "role": "CONTACT",
                    "phone": "+1 (857) 410-1816",
                    "email": "clinicaltrials@akouos.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kathy Reape, MD",
                    "affiliation": "Akouos, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Iowa",
                    "status": "RECRUITING",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kesten Anderson",
                            "role": "CONTACT",
                            "phone": "319-356-8320",
                            "email": "Kesten-Anderson@uiowa.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "Children's Hospital of Philadelphia",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19146",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aminat Adegbuji",
                            "role": "CONTACT",
                            "phone": "267-426-8380",
                            "email": "adegbujia@chop.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "National Taiwan University Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei City",
                    "zip": "100",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Wan-Cian Liao",
                            "role": "CONTACT",
                            "phone": "+886- 953-728-657",
                            "email": "mulong0328@gmail.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "University College London",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "NW1 2PG",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "UCLH.OTOF.Study@nhs.net"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000034381",
                    "term": "Hearing Loss"
                },
                {
                    "id": "D000003638",
                    "term": "Deafness"
                },
                {
                    "id": "D000006319",
                    "term": "Hearing Loss, Sensorineural"
                },
                {
                    "id": "D000006312",
                    "term": "Hearing Loss, Bilateral"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006311",
                    "term": "Hearing Disorders"
                },
                {
                    "id": "D000004427",
                    "term": "Ear Diseases"
                },
                {
                    "id": "D000010038",
                    "term": "Otorhinolaryngologic Diseases"
                },
                {
                    "id": "D000012678",
                    "term": "Sensation Disorders"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M24420",
                    "name": "Hearing Loss",
                    "asFound": "Hearing Loss",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6840",
                    "name": "Deafness",
                    "asFound": "Hearing Loss",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9407",
                    "name": "Hearing Loss, Sensorineural",
                    "asFound": "Sensorineural Hearing Loss",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9401",
                    "name": "Hearing Loss, Bilateral",
                    "asFound": "Hearing Loss, Bilateral",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9400",
                    "name": "Hearing Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7601",
                    "name": "Ear Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12961",
                    "name": "Otorhinolaryngologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15490",
                    "name": "Sensation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "T547",
                    "name": "Auditory Neuropathy Spectrum Disorder",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC09",
                    "name": "Ear, Nose, and Throat Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}